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Abstract 
Aim 
This study is a questionnaire survey of delegates attending the chronic pancreatitis symposium at the 
2016 meeting of the Pancreatic Society of Gt.Britain and Ireland and seeks a multidisciplinary 
“snapshot” overview of practice. 
Methods 
A questionnaire was developed with multidisciplinary input.  Questions on access to specialist care, 
methods of diagnosis and treatment including specific scenarios were incorporated. Eighty three (66%) 
of 125 delegates replied.   
Results 
Twenty-four (29%) had neither a chronic pancreatitis MDT in their hospital nor a chronic pancreatitis 
referral MDT.  Most frequently utilised diagnostic modalities were CT, MR and EUS with no 
respondents utilising duodenal intubation tests.  Initial treatment was non-opiate analgesia by 69 (93%), 
opiates 56 (76%) and co-analgesics 49 (66%). Fifty two (68%) routinely referred patients with alcohol-
related disease for counselling.  Preferred treatment for large duct disease without mass was 
endoscopic therapy. In older patients with a mass pancreaticoduodenectomy was preferred. 
Conclusion 
This is a small study likely to be skewed by sampling bias but is thought to be the first multidisciplinary 
survey of the management of chronic pancreatitis in the UK and Ireland.  The results show a need for 
comprehensive access to specialist pancreatitis MDT care and that there remains substantial variation 
in management. 
[200 words]. 
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Introduction 
The practical management of chronic pancreatitis can be complex [1].  Modern clinical management 
favours a multidisciplinary approach to treatment.  Part of the difficulty in managing chronic pancreatitis 
arises from the relatively limited evidence base for selection of treatment options.  Although there are 
international and national guidelines for the management of chronic pancreatitis, the evidence for 
selection of treatment is less clear [1].  In terms of baseline treatments there are a series of relatively 
small randomised trials evaluating treatments such as the role of alcohol avoidance counselling in 
preventing re-admission in the early stages of the disease, gabapentin for symptom control, and 
micronutrient antioxidant therapy [2-4].  In terms of further treatment there are small randomised trials 
comparing endoscopic to surgical intervention but a large part of the body of evidence on either 
endoscopic or surgical treatment derives from case series reporting outcome [5-6].  Given the often 
conflicting outcomes of these reports, the literature does not support a 'best-practice' option in many 
settings.   
This report arises from a conference questionnaire delivered to participants in the annual meeting of the 
Pancreatic Society of Great Britain and Ireland, held in Manchester in 2016.  The meeting incorporated 
a symposium entitled “The practical management of chronic pancreatitis” featuring lectures on the 
diagnosis and treatment of this disease.  Audience viewpoints were sought on answers to key 
questions around diagnostic standards, baseline treatment and selection for endoscopic or surgical 
intervention.  Participants were provided with a questionnaire and this report is a detailed description of 
the responses to these questions.  It should be noted that these responses constitute neither a 
consensus conference nor an official position statement of the Pancreatic Society of Great Britain and 
Ireland.  Rather, these replies represent the responses of a multidisciplinary group of congress 
participants at this specialist society meeting. 
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Methods 
Setting 
This study took place during the chronic pancreatitis symposium at the 2016 annual meeting of the 
Pancreatic Society of Great Britain and Ireland in Manchester. 
Design of questionnaire 
The questionnaire was designed to include a maximum of 10 key questions.  The questionnaire can be 
seen in the appendix.   The questionnaire was produced with input from a multidisciplinary panel 
comprising dietitians, physicians with an interest in pancreatology and pancreatic surgeons.  The 
structure of the questionnaire followed a format of establishing the speciality of the respondent and then 
addressing the diagnosis and baseline treatment of chronic pancreatitis.  In order to further explore 
specific aspects of management (for example the management of a patient with a pancreatic head 
mass) a series of scenario-based questions examining respondents views were incorporated into the 
questionnaire.  These scenarios included large duct chronic pancreatitis, small duct chronic disease 
and the patient with a pancreatic head mass.  
Implementation of questionnaire 
Paper copies were provided to all symposium participants. The session chairmen (KC and AKS) 
explained both at the start of the session and at the end that participation was strictly on a voluntary 
basis. In addition, the front page of the questionnaire included a question asking whether attendees 
wished to participate.  Respondents had the option to remain anonymous; those who indicated that 
they wished to be named are acknowledged at the end of this manuscript.  Questionnaires could be 
completed during the symposium and all response sheets were collected at the end of the session.   A 
total of 125 questionnaires were handed out to delegates entering the symposium. 
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Collation of results of questionnaire 
The questionnaire allowed multiple responses to a single question.  Therefore, if there was at least one 
ticked box in reply to a question, this question was regarded as answered. If there was no reply to any 
option, the question was regarded as unanswered.  Results were collated onto an electronic database.  
Not all respondents answered all questions and thus the denominator for individual questions could 
differ.  The specific denominator for each question is provided individually. 
Analysis 
The Stats direct software (Altrincham, UK) was used for analyses.  Categorical data were analysed by 
contingency tables using Fisher’s exact test to assess for differences between professional groups 
accepting significance at the P <0.05 level. 
Ethics 
Investigators were advised by the Research and Development department of Central Manchester 
University Hospitals NHS Foundation Trust that no formal ethics committee approval was required as 
the study has no clinical contact. 
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Results 
Study population 
A total of 83 (66%) delegates completed the questionnaires.  These were collected at the end of the 
session and constitute the study population. By category of respondent there were 32 (39% of study 
population) consultant pancreatic surgeons, 20 (24%) Consultant Gastroenterologist/Pancreatologists, 
18 (22%) dietitians, 12 (14%) trainees (not further categorised) and 1 (1%) specialist nurse.   
 
Access to specialist chronic pancreatitis care 
There were 82 respondents to this question.  Forty four (54%) worked in hospitals which had a 
specialist chronic pancreatitis MDT. A further 14 (17%) had access to a pancreatitis MDT to which they 
could refer patients.  Twenty-four (29%) of respondents had neither a chronic pancreatitis MDT in their 
hospital nor an external chronic pancreatitis MDT to which they could refer patients.  Fifty eight (71%) of 
respondents had access to a dietitian specialising in pancreatic disease. 
 
Diagnosis of chronic pancreatitis. 
There were 78 respondents to this question.  Replies are seen in Table 1.  The most frequently used 
modalities were CT, MR and endoscopic ultrasound. 
 
Monitoring of patients with chronic pancreatitis. 
There were 81 respondents to this question.  Fifty six (69%) had a Pancreatic Enzyme Replacement 
Therapy (PERT) protocol in their unit.  Fifty seven (70%) routinely monitored patients for development 
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of diabetes mellitus.  Fifty five (68%) undertook bone density monitoring, and 20 (25%) undertook 
surveillance for pancreatic cancer (details unspecified). 
 
Initial treatment of chronic pancreatitis. 
There were 74 respondents to this question.  The replies are seen in Table 2.  By specialty, 12 of 31 
(39%) surgeon respondents to this question used celiac plexus block compared to 5 of 17 (29%) 
physician respondents (P=0.75; Fisher’s exact test). No physicians used thoracoscopic splanchnotomy 
whereas two surgeons used this.  Ten of 31 (32%) surgeons referred patients for specialist endoscopic 
intervention compared to 6 of 17 (35%) of physicians (P=0.78).  Eleven (35%) surgeons referred 
patients for specialist surgical intervention compared to 7 (41%) of physicians (P=0.76; Fisher’s exact 
test). 
 
Counselling on alcohol and tobacco avoidance 
There were 76 respondents to this question.  Fifty two (68%) routinely referred patients with alcohol-
related chronic pancreatitis for alcohol counselling.  Thirty six (47%) referred patients for counselling to 
stop cigarette smoking.  Forty five (59%) insisted on alcohol abstinence before surgery with a median 
(range) duration of 6 (0 – 12) months. 
 
Scenario 1: What is the preferred initial intervention in a young patient (<40 years of age) with painful 
large duct chronic pancreatitis, parenchymal calcification and no mass? 
There were 67 responses to this question and more than one response was permitted. Thirty seven 
(55%) respondents chose endoscopic therapy. Twenty-one (31%) chose lateral 
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pancreaticojejunostomy, 21 (31%) chose the Frey procedure and 7 (10%) chose the Beger procedure. 
Two respondents selected total pancreatectomy with islet auto-transplantation. 
By specialty 14/31 (45%) surgeons selected endoscopic intervention as their initial preferred choice 
compared to 11/17 (65%) physicians (P=0.24; Fisher’s exact test). Lateral pancreaticojejunostomy was 
selected by 12 (39%) surgeons compared to 3 (18%) physicians (P=0.19; Fisher’s exact test). 
 
Scenario 2: What is the preferred intervention in an older patient (>50 years of age) with painful large 
duct chronic pancreatitis, parenchymal calcification and a pancreatic head mass and negative cytology 
from EUS-FNA. 
There were 67 respondents to this question and more than one response was permitted. 
Pancreaticoduodenectomy was selected by 34 (51%) and the Frey procedure by 26 (39%).  
Endoscopic therapy was selected by 21 (31%) and the Beger procedure was selected by 15 (22%). By 
specialty 8 (26%) of surgeons chose endoscopic intervention compared to 7 (41%) physicians (P=0.33; 
Fisher’s exact). Eight (26%) surgeons chose the Beger procedure compared to 2 (12%) physicians 
(P=0.45; Fisher’s exact). Pancreaticoduodenectomy was selected by 8 (26%) surgeons and 10 (59%) 
physicians (P=0.03; Fisher’s exact). Eight surgeons (26%) selected total pancreatectomy with islet auto 
transplantation compared to 0 physicians (P=0.03, Fisher’s exact). 
 
Scenario 3: What is the preferred intervention in a younger patient (<40 years of age) with painful small 
duct chronic pancreatitis, minimal parenchymal calcification and no pancreatic head mass  
There were 67 respondents to this question and more than one response was permitted. Forty nine 
(73%) respondents stated that they would undertake no intervention. Endoscopic therapy was selected 
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by 13 (19%).  The Izbicki procedure was selected by 13 (19%) and total pancreatectomy with islet auto 
transplantation by 5 (7%). 
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Discussion 
This paper is a report based on a questionnaire administered during the chronic pancreatitis 
symposium at the 2016 annual meeting of the Pancreatic Society of Great Britain and Ireland.  The 
questionnaire explores respondents’ views on the diagnosis and treatment of chronic pancreatitis and 
also uses specific scenarios to assess treatment.  It is important to appreciate the limitations of this 
study.  First, this is a small sample.  Second, it is likely to be skewed by sampling bias as respondents 
are likely to have an interest in the management of chronic pancreatitis. In this regard as there could 
have been more than one respondent from any particular institution there could have been over-
representation of some units compared to others).  Third, answers to questionnaire surveys indicate 
hypothetical responses which may not translate into practice. Hence over-interpretation of the findings 
should be avoided. 
If the results of this survey are viewed in the light of these limitations, there are some interesting and 
potentially important findings.  This is likely the first multidisciplinary survey of the management of 
patients with chronic pancreatitis in the United Kingdom and Ireland.  In this context, the population of 
83 respondents could be argued to be a representative cross-section of the community treating these 
patients with the exception of radiologists and specialist nurses. 
The first interesting finding is that 24 (29%) of respondents had neither a chronic pancreatitis MDT in 
their hospital nor an external MDT to which they could refer patients. This finding is of concern and the 
findings require more systematic verification.  Mainstays for the diagnosis of chronic pancreatitis include 
CT and endoscopic ultrasound.  It is noteworthy that 16 (21%) of respondents stated that they used 
ERCP in diagnosis of chronic pancreatitis.  This is a surprising finding given that diagnostic ERCP is no 
longer a part of the routine diagnostic work-up in chronic pancreatitis.  Although the question on 
diagnosis clearly specified whether ERCP was used for diagnosis (see appendix) it is possible that 
respondents regarded diagnosis and therapy as a combined procedure.  
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It is noteworthy that no respondents utilise duodenal intubation tests.  Given the relative paucity of 
evidence for the early treatment of chronic pancreatitis, the range of treatments is broad.  Treatments 
such as thoracoscopic splanchnotomy are rarely used. Referral of patients for counselling on alcohol or 
tobacco avoidance is not universal.  Recent evidence on tobacco smoking as a potentially modifiable 
risk factor and hence the value of counselling to stop smoking should be more broadly incorporated into 
care pathways [7]. There are no United Kingdom guidelines on issues such as alcohol avoidance 
before surgery and there was a range of responses in relation to the question on duration of time for 
abstinence prior to surgery.  
In terms of the clinical scenarios, the first setting of the young patient with large duct disease, 55% of 
respondents chose endoscopic therapy and 31% selected lateral pancreaticojejunostomy. This is 
interesting in light of the randomised trial evidence favouring surgery [8].  There was no difference 
between surgeons and physicians in the choice of procedure. In the second scenario of the older 
patient with large duct disease but with a pancreatic head mass, pancreaticoduodenectomy was the 
favoured option, being selected by 51%. This response is broadly in keeping with the evidence from the 
ChroPac trial which did not show superiority of duodenum-preserving pancreatic head resection 
compared to pancreaticoduodenectomy [9] 
This option was selected by significantly more physicians than surgeons (26% vs 59%; P = 0.03).  This 
difference is likely accounted for by surgeons selecting a range of surgical procedures. In the final 
scenario of the young patient with small duct disease, 73% of respondents stated that they would 
undertake no intervention. 
To set these findings in context, the results can be compared to the findings of two important similar 
studies.  The first was a questionnaire survey of the management of chronic pancreatitis in Ireland [10]. 
Chonchubhair’s study surveyed both primary care practitioners and hospital specialists and revealed 
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that in addition to deficits in care there was a lack of familiarity with guidelines.  The second was a 
Dutch national survey of the management of chronic pancreatitis [11].  This showed similar patterns of 
diagnostic strategy to the present study. 
In summary this study reports a questionnaire survey undertaken at the 2016 annual meeting of the 
Pancreatic Society of Gt.Britain and Ireland.  The results indicate that not all respondents have access 
to a specialist pancreatitis MDT at which the care of their patients can be discussed.  Tests used for 
diagnosis of chronic pancreatitis would be in compliance with international diagnostic criteria.  There is 
no clear-cut consensus on initial treatment of chronic pancreatitis.  It would potentially be of interest to 
explore the findings of this study in a national survey of clinicians involved in the care of patients with 
chronic pancreatitis. 
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Table 1: Tests used for the diagnosis of chronic pancreatitis. 
 
 
 
 
 
Tests utilised for the 
diagnosis of chronic 
pancreatitis 
 
Number of respondents 
(n = 78) 
 
Computed tomography 
 
77 (99%) 
 
Magnetic resonance scan 
 
44 (56%) 
 
Secretin-stimulated MR 
 
26 (33%) 
 
ERCP 
 
16 (21%) 
 
Endoscopic ultrasound 
 
60 (77%) 
 
Faecal elastase 
 
46 (59%) 
 
Duodenal intubation test 
 
0 
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Table 2: The initial treatment of chronic pancreatitis. 
 
 
   
The initial treatment of 
chronic pancreatitis 
 
Number of respondents 
(n = 74) 
Non-opiate analgesia 69 (93%) 
Opiate analgesia 56 (76%) 
Co-analgesics 49 (66%) 
Micronutrient anti-oxidant 
therapy 
9 (12%) 
Celiac plexus block 22 (30%) 
Thoracoscopic 
splanchnotomy 
2 (3%) 
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Table legends: 
 
Legend Table 1: Tests used for the diagnosis of chronic pancreatitis. 
MR = magnetic resonance scan.  ERCP = endoscopic retrograde cholangiopancreatography. 
 
Legend Table 2: The initial treatment of chronic pancreatitis. 
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Appendix  
PRACTICAL MANAGEMENT OF CHRONIC PANCREATITIS:  
SYMPOSIUM AT PANCREATIC SOCIETY MEETING, MANCHESTER 2016. 
 
Thank you for attending this symposium.  To enhance the educational experience, we 
have put together a short questionnaire.  Please note that this questionnaire does not 
represent an official document of the Pancreatic Society of Gt.Britain and Ireland.  
However, if the findings are of sufficient interest, we may seek to report the outcomes. 
Therefore we ask whether you would consent for your anonymised replies to be included 
in the response document.  Place a tick in the box if you agree 
 
Further, if you would wish to be listed as a symposium participant and collaborating 
author in any subsequent publication place a tick in the box and provide contact details at 
the end of the questionnaire.  
 
Please now address the following 10 questions: 
 
1. Participant’s specialty: 
Would you indicate your main specialty please? 
A Dietician 
B Nurse specialist 
C Basic Scientist 
D Physician/Pancreatologist 
E Surgeon/Pancreatic Surgeon 
F Trainee 
 
 
 
 
20 
 
2. Access to specialist care: 
Does your hospital have a specialist chronic pancreatitis or 
pancreatitis MDT? 
 
YES/NO 
If you answered NO above, do you have access to a specialist 
pancreatitis MDT to which you can refer patients? 
 
YES/NO 
Do all your patients with chronic pancreatitis have access to a 
dietician specialising in pancreatic disease?   
 
YES/NO 
 
 
3. Diagnosis: 
In addition to history, examination and routine blood tests which of the following 
tests would you use for diagnosis (tick as many as you wish): 
CT  
MR  
Secretin-stimulated 
MR/MRCP 
 
ERCP  
EUS (± FNA)  
Glucose tolerance test  
Glycosylated 
haemoglobin 
 
Faecal elastase  
Duodenal intubation for 
exocrine assessment 
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4. Monitoring: 
Does your unit have a Pancreatic Enzyme Replacement 
Therapy (PERT) protocol?   
YES/NO 
Do you routinely monitor ENDOCRINE function in patients 
with chronic pancreatitis? 
YES/NO 
Do you have access to bone density measurement in 
patients with CP? 
YES/NO 
Do you have a surveillance protocol to detect cancer in 
chronic pancreatitis? 
YES/NO 
 
 
 
 
 
5. Initial treatment of chronic pancreatitis: 
What are your broad first treatment steps (select as many as are appropriate) 
 
Non-opiate analgesia  
Opiate analgesia  
Co-analgesics (e.g. Gabapentin)  
Anti-oxidant therapy  
Endoscopic celiac plexus block  
Thoracoscopic splanchnic nerve division  
Referral for specialist endoscopic intervention  
Referral for specialist surgical intervention.  
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6. Counselling on alcohol and tobacco mis-use: 
 
Do you routinely refer for counselling for alcohol 
cessation?  
YES/NO 
Do you routinely refer for counselling to stop smoking? YES/NO 
Do you insist on a period of alcohol abstinence before 
surgery? 
YES/NO 
If so how long should this period be?  
 
 
 
 
7. Further interventional treatment of chronic pancreatitis: 
In a young patient (<40 years of age) with painful large duct chronic pancreatitis, 
parenchymal calcification and no mass what is your PREFERRED intervention following 
on from initial treatment above (you can indicate more than one response)? 
 
Endoscopic therapy (includes stents and dilatation)  
Endoscopic therapy with ESWL + stent(s)  
Surgical lateral pancreaticojejunostomy  
Beger operation (duodenum-preserving pancreatic head 
resection). 
 
Frey operation (LPJ + coring of pancreatic head).  
Total pancreatectomy with islet auto-transplantation  
None (watch and wait)  
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8. Further interventional treatment of chronic pancreatitis: 
In an older patient(>50 years of age) with painful large duct chronic pancreatitis, 
parenchymal calcification and a pancreatic head mass and negative cytology from EUS-
FNA what is your PREFERRED intervention following on from initial treatment 
responses to question 5. (You can indicate more than one response)? 
 
Endoscopic therapy (includes stents and dilatation)  
Endoscopic therapy with ESWL + stent(s)  
Surgical lateral pancreaticojejunostomy  
Beger operation (duodenum-preserving pancreatic head 
resection). 
 
Frey operation (LPJ + coring of pancreatic head).  
Pancreaticoduodenectomy (Whipple or PPPD)  
Total pancreatectomy with islet auto-transplantation  
No intervention (watch and wait)  
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9. Further interventional treatment of chronic pancreatitis: 
In a younger patient (<40 years of age) with painful small duct chronic pancreatitis, 
minimal parenchymal calcification and no pancreatic head mass what is your 
PREFERRED intervention following on from initial treatment above (you can indicate 
more than one response)? 
 
Endoscopic therapy (includes stents and dilatation)  
Endoscopic therapy with ESWL + stent(s)  
Surgical lateral pancreaticojejunostomy  
Beger operation (duodenum-preserving pancreatic head 
resection). 
 
Frey operation (LPJ + coring of pancreatic head).  
Izbicki “V” shaped excision operation  
Total pancreatectomy with islet auto-transplantation  
None (watch and wait)  
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10. Complications of chronic pancreatitis: 
Management of benign biliary stricture (tick as appropriate) 
Endoscopic biliary stent placement is the preferred first treatment. YES/NO 
Covered metallic stent is preferable to plastic stent. YES/NO 
In older patients, biliary stenting can be used as definitive treatment YES/NO 
In patients < 50 years, a persistent biliary stricture may be regarded 
as an indication for surgery. 
YES/NO 
 
 
Thank you for your participation. 
 
PARTICIPANT NAME: 
 
 
PARTICIPANT’S INSTITUTION: 
 
 
PARTICIPANT’S EMAIL ADDRESS: 
 
